Methods
A markov model was used to estimate the cost-utility of FeNO versus
standard treatment (control group) an infant with mild to moderate
allergic asthma. Cost data were obtained from a retrospective study on
asthma from tertiary center, in Medellin, Colombia, while utilities were
collected from the literature. The analysis was carried out from a
societal perspective.